Fortis Healthcare Ltd is facilitating the sale of stakes owned by private equity investors in its SRL Diagnostics unit, two people aware of the matter said. Fortis, which owns 57% in SRL Diagnostics, is in the process of hiring Kotak Mahindra Bank as an investment banker to manage the transaction, one of the two people said on condition of anonymity.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
